Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH

被引:625
作者
Svastová, E
Hulíková, A
Rafajová, M
Zat'ovicová, M
Gibadulinová, A
Casini, A
Cecchi, A
Scozzafava, A
Supuran, CT
Pastorek, J
Pastoreková, S
机构
[1] Slovak Acad Sci, Inst Virol, Ctr Mol Med, Bratislava 84505, Slovakia
[2] Univ Firenze, Chim Bioorgan Lab, I-50019 Florence, Italy
关键词
tumor microenvironment; acidosis; carbonic anhydrase IX; hypoxia; sulfonamide;
D O I
10.1016/j.febslet.2004.10.043
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acidic extracellular pH (pHe) is a typical attribute of a tumor microenviroment, which has an impact on cancer development and treatment outcome. It was believed to result from an accumulation of lactic acid excessively produced by glycolysis. However, metabolic profiles of glycolysis-impaired tumors have revealed that CO2 is a significant source of acidity, thereby indicating a contribution of carbonic anhydrase (CA). The tumor-associated CA IX isoform is the best candidate, because its extracellular enzyme domain is highly active, expression is induced by hypoxia and correlates with poor prognosis. This study provides the first evidence for the role of CA IX in the control of pHe. We show that CA IX can acidify the pH of the culture medium in hypoxia but not in normoxia. This acidification can be perturbed by deletion of the enzyme active site and inhibited by CA IX-selective sulfonamides, which bind only to hypoxic cells containing CA IX. Our findings suggest that hypoxia regulates both expression and activity of CA IX in order to enhance the extracellular acidification, which may have important implications for tumor progression. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:439 / 445
页数:7
相关论文
共 32 条
  • [1] Sulfonamides and Sulfonylated Derivatives as Anticancer Agents
    Casini, Angela
    Scozzafava, Andrea
    Mastrolorenzo, Antonio
    Supuran, Claudiu T.
    [J]. CURRENT CANCER DRUG TARGETS, 2002, 2 (01) : 55 - 75
  • [2] Acidic pH inhibits non-MHC-restricted killer cell functions
    Fischer, B
    Müller, B
    Fischer, KG
    Baur, N
    Kreutz, W
    [J]. CLINICAL IMMUNOLOGY, 2000, 96 (03) : 252 - 263
  • [3] Fukumura D, 2001, CANCER RES, V61, P6020
  • [4] Tumor pH: Implications for treatment and novel drug design
    Gerweck, LE
    [J]. SEMINARS IN RADIATION ONCOLOGY, 1998, 8 (03) : 176 - 182
  • [5] Helmlinger G, 2002, CLIN CANCER RES, V8, P1284
  • [6] Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes
    Ivanov, SV
    Kuzmin, I
    Wei, MH
    Pack, S
    Geil, L
    Johnson, BE
    Stanbridge, EJ
    Lerman, MI
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) : 12596 - 12601
  • [7] VHL tumor suppressor regulates Cl-/HCO3- exchange and Na+/H+ exchange activities in renal carcinoma cells
    Karumanchi, SA
    Jiang, LW
    Knebelmann, B
    Stuart-Tilley, AK
    Alper, SL
    Sukhatme, VP
    [J]. PHYSIOLOGICAL GENOMICS, 2001, 5 (03) : 119 - 128
  • [8] KATO Y, 1992, J BIOL CHEM, V267, P11424
  • [9] Acidic pH enhances the invasive behavior of human melanoma cells
    MartinezZaguilan, R
    Seftor, EA
    Seftor, REB
    Chu, YW
    Gillies, RJ
    Hendrix, MJC
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 1996, 14 (02) : 176 - 186
  • [10] HIF activation by pH-dependent nucleolar sequestration of VHL
    Mekhail, K
    Gunaratnam, L
    Bonicalzi, ME
    Lee, S
    [J]. NATURE CELL BIOLOGY, 2004, 6 (07) : 642 - 647